Metrics to compare | 300147 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300147PeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.7x | −4.6x | −0.2x | |
PEG Ratio | 0.06 | 0.27 | 0.00 | |
Price/Book | −5.0x | 1.6x | 2.6x | |
Price / LTM Sales | 2.6x | 2.2x | 2.6x | |
Upside (Analyst Target) | - | 36.5% | 77.0% | |
Fair Value Upside | Unlock | 8.9% | 13.7% | Unlock |
Xiangxue Pharmaceutical Co.,Ltd. engages in the research and development, production, and sales of modern Chinese medicine in China. The company provides ban lan gen granules, flu-over liquid, juhong cough-off liquid, and juhong cough-off decoction; chinese herbal, such as huazhou citri grandis, goji berry, chrysanthemum, and rose dried buds; beverages, including king sarsae, asia sarsae, asia diet sarsae, asia juice soda, asia soymilk, coconut juice, and fruit enzyme; and antiviral oral liquids under the Xiangxue brand name. It also provides medical devices, which includes disposable stereoscopic fixation system for brain; medical orthopedic and cosmetic adhesives; medical tumor serosa sealing adhesives; medical anastomotic adhesives; medical aural and encephalic adhesives; medical obturation adhesives; medical adhesives; and endoscopic trocar. Xiangxue Pharmaceutical Co.,Ltd. was founded in 1986 and is based in Guangzhou, China.